Recovery of an infectious virus of defined genetic structure entirely from cDNA and the deduction of information about the virus resulting from phenotypic characterization of the mutant is the process of reverse genetics. This approach has been possible for a number of negative-strand RNA viruses since the recovery of rabies virus in 1994. However, the recovery of recombinant orthomyxoviruses posed a greater challenge due to the segmented nature of the genome. It was not until 1999 that such a system was reported for influenza A viruses, but since that time our knowledge of influenza A virus biology has grown dramatically. Annual influenza epidemics are caused not only by influenza A viruses but also by influenza B viruses. In 2002, two groups reported the successful recovery of influenza B virus entirely from cDNA. This has allowed greater depth of study into the biology of these viruses. This review will highlight the advances made in various areas of influenza B virus biology as a result of the development of reverse genetics techniques for these viruses, including (i) the importance of the non-coding regions of the influenza B virus genome; (ii) the generation of novel vaccine strains; (iii) studies into the mechanisms of drug resistance; (iv) the function(s) of viral proteins, both those analogous to influenza A virus proteins and those unique to influenza B viruses. The information generated by the application of influenza B virus reverse genetics systems will continue to contribute to our improved surveillance and control of human influenza.
Altschul, S. F., Madden, T. L., Schaffer, A. A., Zhang, J., Zhang, Z., Miller, W. & Lipman, D. J.(1997). Gapped blast and psi-blast: a new generation of protein database search programs. Nucleic Acids Res25, 3389–3402.[CrossRef][Google Scholar]
Altschul, S. F., Wootton, J. C., Gertz, E. M., Agarwala, R., Morgulis, A., Schaffer, A. A. & Yu, Y. K.(2005). Protein database searches using compositionally adjusted substitution matrices. FEBS J272, 5101–5109.[CrossRef][Google Scholar]
Balannik, V., Lamb, R. A. & Pinto, L. H.(2008). The oligomeric state of the active BM2 ion channel protein of influenza B virus. J Biol Chem283, 4895–4904.[CrossRef][Google Scholar]
Barclay, W. S. & Palese, P.(1995). Influenza B viruses with site-specific mutations introduced into the HA gene. J Virol69, 1275–1279.
[Google Scholar]
Baum, E. Z., Wagaman, P. C., Ly, L., Turchi, I., Le, J., Bucher, D. & Bush, K.(2003). A point mutation in influenza B neuraminidase confers resistance to peramivir and loss of slow binding. Antiviral Res59, 13–22.[CrossRef][Google Scholar]
Belshe, R. B.(2010). The need for quadrivalent vaccine against seasonal influenza. Vaccine28 (Suppl 4), D45–D53.[CrossRef][Google Scholar]
Belshe, R. B., Coelingh, K., Ambrose, C. S., Woo, J. C. & Wu, X.(2010). Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity. Vaccine28, 2149–2156.[CrossRef][Google Scholar]
Betakova, T., Nermut, M. V. & Hay, A. J.(1996). The NB protein is an integral component of the membrane of influenza B virus. J Gen Virol77, 2689–2694.[CrossRef][Google Scholar]
Brassard, D. L., Leser, G. P. & Lamb, R. A.(1996). Influenza B virus NB glycoprotein is a component of the virion. Virology220, 350–360.[CrossRef][Google Scholar]
Briedis, D. J. & Lamb, R. A.(1982). Influenza B virus genome: sequences and structural organization of RNA segment 8 and the mRNAs coding for the NS1 and NS2 proteins. J Virol42, 186–193.
[Google Scholar]
Briedis, D. J., Lamb, R. A. & Choppin, P. W.(1982). Sequence of RNA segment 7 of the influenza B virus genome: partial amino acid homology between the membrane proteins (M1) of influenza A and B viruses and conservation of a second open reading frame. Virology116, 581–588.[CrossRef][Google Scholar]
Cady, S. D., Schmidt-Rohr, K., Wang, J., Soto, C. S., Degrado, W. F. & Hong, M.(2010). Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers. Nature463, 689–692.[CrossRef][Google Scholar]
Camilloni, B., Neri, M., Lepri, E. & Iorio, A. M.(2009). Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages. Vaccine27, 4099–4103.[CrossRef][Google Scholar]
Carrat, F. & Flahault, A.(2007). Influenza vaccine: the challenge of antigenic drift. Vaccine25, 6852–6862.[CrossRef][Google Scholar]
Chen, Z. & Krug, R. M.(2000). Selective nuclear export of viral mRNAs in influenza-virus-infected cells. Trends Microbiol8, 376–383.[CrossRef][Google Scholar]
Chen, Z., Li, Y. & Krug, R. M.(1999). Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3′-end processing machinery. EMBO J18, 2273–2283.[CrossRef][Google Scholar]
Chen, W., Calvo, P. A., Malide, D., Gibbs, J., Schubert, U., Bacik, I., Basta, S., O'Neill, R., Schickli, J. & other authors(2001). A novel influenza A virus mitochondrial protein that induces cell death. Nat Med7, 1306–1312.[CrossRef][Google Scholar]
Chen, Z., Aspelund, A., Kemble, G. & Jin, H.(2006). Genetic mapping of the cold-adapted phenotype of B/Ann Arbor/1/66, the master donor virus for live attenuated influenza vaccines (FluMist). Virology345, 416–423.[CrossRef][Google Scholar]
Chen, Z., Aspelund, A. & Jin, H.(2008a). Stabilizing the glycosylation pattern of influenza B hemagglutinin following adaptation to growth in eggs. Vaccine26, 361–371.[CrossRef][Google Scholar]
Chen, Z., Aspelund, A., Kemble, G. & Jin, H.(2008b). Molecular studies of temperature-sensitive replication of the cold-adapted B/Ann Arbor/1/66, the master donor virus for live attenuated influenza FluMist vaccines. Virology380, 354–362.[CrossRef][Google Scholar]
Cox, N. J., Kitame, F., Kendal, A. P., Maassab, H. F. & Naeve, C.(1988). Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2). Virology167, 554–567.
[Google Scholar]
Crescenzo-Chaigne, B., Naffakh, N. & van der Werf, S.(1999). Comparative analysis of the ability of the polymerase complexes of influenza viruses type A, B and C to assemble into functional RNPs that allow expression and replication of heterotypic model RNA templates in vivo. Virology265, 342–353.[CrossRef][Google Scholar]
Dauber, B., Heins, G. & Wolff, T.(2004). The influenza B virus nonstructural NS1 protein is essential for efficient viral growth and antagonizes beta interferon induction. J Virol78, 1865–1872.[CrossRef][Google Scholar]
Dauber, B., Schneider, J. & Wolff, T.(2006). Double-stranded RNA binding of influenza B virus nonstructural NS1 protein inhibits protein kinase R but is not essential to antagonize production of alpha/beta interferon. J Virol80, 11667–11677.[CrossRef][Google Scholar]
Dauber, B., Martinez-Sobrido, L., Schneider, J., Hai, R., Waibler, Z., Kalinke, U., Garcia-Sastre, A. & Wolff, T.(2009). Influenza B virus ribonucleoprotein is a potent activator of the antiviral kinase PKR. PLoS Pathog5, e1000473.[CrossRef][Google Scholar]
Davies, W. L., Grunert, R. R., Haff, R. F., McGahen, J. W., Neumayer, E. M., Paulshock, M., Watts, J. C., Wood, T. R., Hermann, E. C. & other authors(1964). Antiviral activity of 1-Adamantanamine (amantadine). Science144, 862–863.[CrossRef][Google Scholar]
DeBorde, D. C., Donabedian, A. M., Herlocher, M. L., Naeve, C. W. & Maassab, H. F.(1988). Sequence comparison of wild-type and cold-adapted B/Ann Arbor/1/66 influenza virus genes. Virology163, 429–443.[CrossRef][Google Scholar]
Desselberger, U. & Palese, P.(1978). Molecular weights of RNA segments of influenza A and B viruses. Virology88, 394–399.[CrossRef][Google Scholar]
Desselberger, U., Racaniello, V. R., Zazra, J. J. & Palese, P.(1980). The 3′ and 5′-terminal sequences of influenza A, B and C virus RNA segments are highly conserved and show partial inverted complementarity. Gene8, 315–328.[CrossRef][Google Scholar]
Donelan, N. R., Dauber, B., Wang, X., Basler, C. F., Wolff, T. & Garcia-Sastre, A.(2004). The N- and C-terminal domains of the NS1 protein of influenza B virus can independently inhibit IRF-3 and beta interferon promoter activation. J Virol78, 11574–11582.[CrossRef][Google Scholar]
Ehrhardt, C., Wolff, T. & Ludwig, S.(2007a). Activation of phosphatidylinositol 3-kinase signaling by the nonstructural NS1 protein is not conserved among type A and B influenza viruses. J Virol81, 12097–12100.[CrossRef][Google Scholar]
Ehrhardt, C., Wolff, T., Pleschka, S., Planz, O., Beermann, W., Bode, J. G., Schmolke, M. & Ludwig, S.(2007b). Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. J Virol81, 3058–3067.[CrossRef][Google Scholar]
Fischer, W. B., Pitkeathly, M. & Sansom, M. S.(2001). Amantadine blocks channel activity of the transmembrane segment of the NB protein from influenza B. Eur Biophys J30, 416–420.[CrossRef][Google Scholar]
Flandorfer, A., Garcia-Sastre, A., Basler, C. F. & Palese, P.(2003). Chimeric influenza A viruses with a functional influenza B virus neuraminidase or hemagglutinin. J Virol77, 9116–9123.[CrossRef][Google Scholar]
Garcia-Sastre, A., Egorov, A., Matassov, D., Brandt, S., Levy, D. E., Durbin, J. E., Palese, P. & Muster, T.(1998). Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology252, 324–330.[CrossRef][Google Scholar]
Garten, R. J., Davis, C. T., Russell, C. A., Shu, B., Lindstrom, S., Balish, A., Sessions, W. M., Xu, X., Skepner, E. & other authors(2009). Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science325, 197–201.[CrossRef][Google Scholar]
Ghenkina, D. B. & Ghendon, Y. Z.(1979). Recombination and complementation between orthomyxoviruses under conditions of abortive infection. Acta Virol23, 97–106.
[Google Scholar]
Gog, J. R., Afonso Edos, S., Dalton, R. M., Leclercq, I., Tiley, L., Elton, D., von Kirchbach, J. C., Naffakh, N., Escriou, N. & other authors(2007). Codon conservation in the influenza A virus genome defines RNA packaging signals. Nucleic Acids Res35, 1897–1907.[CrossRef][Google Scholar]
Goodeve, A. C., Jennings, R. & Potter, C. W.(1985). Reassortants of influenza B viruses for use in vaccines: an evaluation. Arch Virol83, 169–179.[CrossRef][Google Scholar]
Gotlieb, T. & Hirst, G. K.(1954). The experimental production of combination forms of virus. III. The formation of doubly antigenic particles from influenza A and B virus and a study of the ability of individual particles of X virus to yield two separate strains. J Exp Med99, 307–320.[CrossRef][Google Scholar]
Gubareva, L. V., Kaiser, L., Matrosovich, M. N., Soo-Hoo, Y. & Hayden, F. G.(2001a). Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir. J Infect Dis183, 523–531.[CrossRef][Google Scholar]
Gubareva, L. V., Webster, R. G. & Hayden, F. G.(2001b). Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants. Antimicrob Agents Chemother45, 3403–3408.[CrossRef][Google Scholar]
Hai, R., Martinez-Sobrido, L., Fraser, K. A., Ayllon, J., Garcia-Sastre, A. & Palese, P.(2008). Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach. J Virol82, 10580–10590.[CrossRef][Google Scholar]
Hale, B. G., Jackson, D., Chen, Y. H., Lamb, R. A. & Randall, R. E.(2006). Influenza A virus NS1 protein binds p85β and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci U S A103, 14194–14199.[CrossRef][Google Scholar]
Hale, B. G., Randall, R. E., Ortin, J. & Jackson, D.(2008). The multifunctional NS1 protein of influenza A viruses. J Gen Virol89, 2359–2376.[CrossRef][Google Scholar]
Hatakeyama, S., Sugaya, N., Ito, M., Yamazaki, M., Ichikawa, M., Kimura, K., Kiso, M., Shimizu, H., Kawakami, C. & other authors(2007). Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. JAMA297, 1435–1442.
[Google Scholar]
Hatta, M. & Kawaoka, Y.(2003). The NB protein of influenza B virus is not necessary for virus replication in vitro. J Virol77, 6050–6054.[CrossRef][Google Scholar]
Hatta, M., Goto, H. & Kawaoka, Y.(2004). Influenza B virus requires BM2 protein for replication. J Virol78, 5576–5583.[CrossRef][Google Scholar]
Hatta, M., Kohlmeier, C. K., Hatta, Y., Ozawa, M. & Kawaoka, Y.(2009). Region required for protein expression from the stop-start pentanucleotide in the M gene of influenza B virus. J Virol83, 5939–5942.[CrossRef][Google Scholar]
Hay, A. J.(1992). The action of adamantanamines against influenza A viruses: inhibition of the M2 ion channel protein. Semin Virol3, 21–30.
[Google Scholar]
Hayden, F. G., Treanor, J. J., Fritz, R. S., Lobo, M., Betts, R. F., Miller, M., Kinnersley, N., Mills, R. G., Ward, P. & other authors(1999). Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA282, 1240–1246.[CrossRef][Google Scholar]
Hayden, F. G., Gubareva, L. V., Monto, A. S., Klein, T. C., Elliot, M. J., Hammond, J. M., Sharp, S. J. & Ossi, M. J.(2000). Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group. N Engl J Med343, 1282–1289.[CrossRef][Google Scholar]
Hiebert, S. W., Williams, M. A. & Lamb, R. A.(1986). Nucleotide sequence of RNA segment 7 of influenza B/Singapore/222/79: maintenance of a second large open reading frame. Virology155, 747–751.[CrossRef][Google Scholar]
Hoffmann, E., Mahmood, K., Yang, C. F., Webster, R. G., Greenberg, H. B. & Kemble, G.(2002). Rescue of influenza B virus from eight plasmids. Proc Natl Acad Sci U S A99, 11411–11416.[CrossRef][Google Scholar]
Hoffmann, E., Mahmood, K., Chen, Z., Yang, C. F., Spaete, J., Greenberg, H. B., Herlocher, M. L., Jin, H. & Kemble, G.(2005). Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B/Ann Arbor/1/66. J Virol79, 11014–11021.[CrossRef][Google Scholar]
Horimoto, T., Takada, A., Iwatsuki-Horimoto, K., Hatta, M., Goto, H. & Kawaoka, Y.(2003). Generation of influenza A viruses with chimeric (type A/B) hemagglutinins. J Virol77, 8031–8038.[CrossRef][Google Scholar]
Horimoto, T., Iwatsuki-Horimoto, K., Hatta, M. & Kawaoka, Y.(2004a). Influenza A viruses possessing type B hemagglutinin and neuraminidase: potential as vaccine components. Microbes Infect6, 579–583.[CrossRef][Google Scholar]
Horimoto, T., Takada, A., Iwatsuki-Horimoto, K. & Kawaoka, Y.(2004b). A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model. Vaccine22, 2244–2247.[CrossRef][Google Scholar]
Horvath, C. M., Williams, M. A. & Lamb, R. A.(1990). Eukaryotic coupled translation of tandem cistrons: identification of the influenza B virus BM2 polypeptide. EMBO J9, 2639–2647.
[Google Scholar]
Hsu, M. T., Parvin, J. D., Gupta, S., Krystal, M. & Palese, P.(1987). Genomic RNAs of influenza viruses are held in a circular conformation in virions and in infected cells by a terminal panhandle. Proc Natl Acad Sci U S A84, 8140–8144.[CrossRef][Google Scholar]
Huber, V. C., Kleimeyer, L. H. & McCullers, J. A.(2008). Live, attenuated influenza virus (LAIV) vehicles are strong inducers of immunity toward influenza B virus. Vaccine26, 5381–5388.[CrossRef][Google Scholar]
Hutchinson, E. C., von Kirchbach, J. C., Gog, J. R. & Digard, P.(2010). Genome packaging in influenza A virus. J Gen Virol91, 313–328.[CrossRef][Google Scholar]
Imai, M., Watanabe, S., Ninomiya, A., Obuchi, M. & Odagiri, T.(2004). Influenza B virus BM2 protein is a crucial component for incorporation of viral ribonucleoprotein complex into virions during virus assembly. J Virol78, 11007–11015.[CrossRef][Google Scholar]
Imai, M., Kawasaki, K. & Odagiri, T.(2008). Cytoplasmic domain of influenza B virus BM2 protein plays critical roles in production of infectious virus. J Virol82, 728–739.[CrossRef][Google Scholar]
Isaacs, A. & Baron, S.(1960). Antiviral action of interferon in embryonic cells. Lancet2, 946–947.
[Google Scholar]
Iwatsuki-Horimoto, K., Horimoto, T., Noda, T., Kiso, M., Maeda, J., Watanabe, S., Muramoto, Y., Fujii, K. & Kawaoka, Y.(2006). The cytoplasmic tail of the influenza A virus M2 protein plays a role in viral assembly. J Virol80, 5233–5240.[CrossRef][Google Scholar]
Iwatsuki-Horimoto, K., Hatta, Y., Hatta, M., Muramoto, Y., Chen, H., Kawaoka, Y. & Horimoto, T.(2008). Limited compatibility between the RNA polymerase components of influenza virus type A and B. Virus Res135, 161–165.[CrossRef][Google Scholar]
Jackson, D., Cadman, A., Zurcher, T. & Barclay, W. S.(2002). A reverse genetics approach for recovery of recombinant influenza B viruses entirely from cDNA. J Virol76, 11744–11747.[CrossRef][Google Scholar]
Jackson, D., Zurcher, T. & Barclay, W.(2004). Reduced incorporation of the influenza B virus BM2 protein in virus particles decreases infectivity. Virology322, 276–285.[CrossRef][Google Scholar]
Jackson, D., Barclay, W. & Zurcher, T.(2005). Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations. J Antimicrob Chemother55, 162–169.[CrossRef][Google Scholar]
Jackson, D., Killip, M. J., Galloway, C. S., Russell, R. J. & Randall, R. E.(2010). Loss of function of the influenza A virus NS1 protein promotes apoptosis but this is not due to a failure to activate phosphatidylinositol 3-kinase (PI3K). Virology396, 94–105.[CrossRef][Google Scholar]
Kawai, N., Ikematsu, H., Iwaki, N., Maeda, T., Satoh, I., Hirotsu, N. & Kashiwagi, S.(2006). A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003–2004 and 2004–2005 influenza seasons. Clin Infect Dis43, 439–444.[CrossRef][Google Scholar]
Kilbourne, E. D.(1969). Future influenza vaccines and the use of genetic recombinants. Bull World Health Organ41, 643–645.
[Google Scholar]
Kim, C. U., Lew, W., Williams, M. A., Liu, H., Zhang, L., Swaminathan, S., Bischofberger, N., Chen, M. S., Mendel, D. B. & other authors(1997). Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. J Am Chem Soc119, 681–690.[CrossRef][Google Scholar]
Koudstaal, W., Hartgroves, L., Havenga, M., Legastelois, I., Ophorst, C., Sieuwerts, M., Zuijdgeest, D., Vogels, R., Custers, J. & other authors(2009). Suitability of PER.C6 cells to generate epidemic and pandemic influenza vaccine strains by reverse genetics. Vaccine27, 2588–2593.[CrossRef][Google Scholar]
Lackenby, A., Thompson, C. I. & Democratis, J.(2008). The potential impact of neuraminidase inhibitor resistant influenza. Curr Opin Infect Dis21, 626–638.[CrossRef][Google Scholar]
Lamb, R. A. & Krug, R. M.(2001).Orthomyxoviridae: The Viruses and Their Replication. In Fields Virology, 4th edn, pp. 1487–1531. Edited by Knipe, D. M. & Howley, P. M.. Philadelphia. : Lippincott Williams & Wilkins.
[Google Scholar]
Lee, Y. S. & Seong, B. L.(1996). Mutational analysis of influenza B virus RNA transcription in vitro. J Virol70, 1232–1236.
[Google Scholar]
Lee, Y. S. & Seong, B. L.(1998). Nucleotides in the panhandle structure of the influenza B virus virion RNA are involved in the specificity between influenza A and B viruses. J Gen Virol79, 673–681.
[Google Scholar]
Lenschow, D. J., Lai, C., Frias-Staheli, N., Giannakopoulos, N. V., Lutz, A., Wolff, T., Osiak, A., Levine, B., Schmidt, R. E. & other authors(2007). IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci U S A104, 1371–1376.[CrossRef][Google Scholar]
Lin, Y. P., Gregory, V., Bennett, M. & Hay, A.(2004). Recent changes among human influenza viruses. Virus Res103, 47–52.[CrossRef][Google Scholar]
Lugovtsev, V. Y., Vodeiko, G. M., Strupczewski, C. M., Ye, Z. & Levandowski, R. A.(2007). Generation of the influenza B viruses with improved growth phenotype by substitution of specific amino acids of hemagglutinin. Virology365, 315–323.[CrossRef][Google Scholar]
Lugovtsev, V. Y., Smith, D. F. & Weir, J. P.(2009). Changes of the receptor-binding properties of influenza B virus B/Victoria/504/2000 during adaptation in chicken eggs. Virology394, 218–226.[CrossRef][Google Scholar]
Luo, C., Nobusawa, E. & Nakajima, K.(1999). An analysis of the role of neuraminidase in the receptor-binding activity of influenza B virus: the inhibitory effect of Zanamivir on haemadsorption. J Gen Virol80, 2969–2976.
[Google Scholar]
Luytjes, W., Krystal, M., Enami, M., Parvin, J. D. & Palese, P.(1989). Amplification, expression, and packaging of foreign gene by influenza virus. Cell59, 1107–1113.[CrossRef][Google Scholar]
Ma, C., Soto, C. S., Ohigashi, Y., Taylor, A., Bournas, V., Glawe, B., Udo, M. K., Degrado, W. F., Lamb, R. A. & other authors(2008). Identification of the pore-lining residues of the BM2 ion channel protein of influenza B virus. J Biol Chem283, 15921–15931.[CrossRef][Google Scholar]
Maassab, H. F.(1967). Adaptation and growth characteristics of influenza virus at 25 degrees c. Nature213, 612–614.[CrossRef][Google Scholar]
Maassab, H. F. & DeBorde, D. C.(1985). Development and characterization of cold-adapted viruses for use as live virus vaccines. Vaccine3, 355–369.[CrossRef][Google Scholar]
Mazur, I., Anhlan, D., Mitzner, D., Wixler, L., Schubert, U. & Ludwig, S.(2008). The proapoptotic influenza A virus protein PB1–F2 regulates viral polymerase activity by interaction with the PB1 protein. Cell Microbiol10, 1140–1152.[CrossRef][Google Scholar]
McAuley, J. L., Hornung, F., Boyd, K. L., Smith, A. M., McKeon, R., Bennink, J., Yewdell, J. W. & McCullers, J. A.(2007). Expression of the 1918 influenza A virus PB1–F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe2, 240–249.[CrossRef][Google Scholar]
McCown, M. F. & Pekosz, A.(2005). The influenza A virus M2 cytoplasmic tail is required for infectious virus production and efficient genome packaging. J Virol79, 3595–3605.[CrossRef][Google Scholar]
McCown, M. F. & Pekosz, A.(2006). Distinct domains of the influenza a virus M2 protein cytoplasmic tail mediate binding to the M1 protein and facilitate infectious virus production. J Virol80, 8178–8189.[CrossRef][Google Scholar]
McCullers, J. A., Wang, G. C., He, S. & Webster, R. G.(1999). Reassortment and insertion-deletion are strategies for the evolution of influenza B viruses in nature. J Virol73, 7343–7348.
[Google Scholar]
McCullers, J. A., Saito, T. & Iverson, A. R.(2004). Multiple genotypes of influenza B virus circulated between 1979 and 2003. J Virol78, 12817–12828.[CrossRef][Google Scholar]
McCullers, J. A., Hoffmann, E., Huber, V. C. & Nickerson, A. D.(2005). A single amino acid change in the C-terminal domain of the matrix protein M1 of influenza B virus confers mouse adaptation and virulence. Virology336, 318–326.[CrossRef][Google Scholar]
McGeoch, D., Fellner, P. & Newton, C.(1976). Influenza virus genome consists of eight distinct RNA species. Proc Natl Acad Sci U S A73, 3045–3049.[CrossRef][Google Scholar]
McKimm-Breschkin, J. L.(2000). Resistance of influenza viruses to neuraminidase inhibitors – a review. Antiviral Res47, 1–17.[CrossRef][Google Scholar]
Meindl, P. & Tuppy, H.(1969). 2-Deoxy-2,3-dehydrosialic acids. II. Competitive inhibition of Vibrio cholerae neuraminidase by 2-deoxy-2,3-dehydro-N-acylneuraminic acids. Hoppe Seylers Z Physiol Chem350, 1088–1092.[CrossRef][Google Scholar]
Monto, A. S., Pichichero, M. E., Blanckenberg, S. J., Ruuskanen, O., Cooper, C., Fleming, D. M. & Kerr, C.(2002). Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households. J Infect Dis186, 1582–1588.[CrossRef][Google Scholar]
Mould, J. A., Paterson, R. G., Takeda, M., Ohigashi, Y., Venkataraman, P., Lamb, R. A. & Pinto, L. H.(2003). Influenza B virus BM2 protein has ion channel activity that conducts protons across membranes. Dev Cell5, 175–184.[CrossRef][Google Scholar]
Nemeroff, M. E., Barabino, S. M., Li, Y., Keller, W. & Krug, R. M.(1998). Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3′ end formation of cellular pre-mRNAs. Mol Cell1, 991–1000.[CrossRef][Google Scholar]
Neumann, G. & Kawaoka, Y.(2001). Reverse genetics of influenza virus. Virology287, 243–250.[CrossRef][Google Scholar]
Odagiri, T., Hong, J. & Ohara, Y.(1999). The BM2 protein of influenza B virus is synthesized in the late phase of infection and incorporated into virions as a subviral component. J Gen Virol80, 2573–2581.
[Google Scholar]
Ohigashi, Y., Ma, C., Jing, X., Balannick, V., Pinto, L. H. & Lamb, R. A.(2009). An amantadine-sensitive chimeric BM2 ion channel of influenza B virus has implications for the mechanism of drug inhibition. Proc Natl Acad Sci U S A106, 18775–18779.[CrossRef][Google Scholar]
Osterhaus, A. D., Rimmelzwaan, G. F., Martina, B. E., Bestebroer, T. M. & Fouchier, R. A.(2000). Influenza B virus in seals. Science288, 1051–1053.[CrossRef][Google Scholar]
Palese, P. & Shaw, M. L.(2007).Orthomyxoviridae: The viruses and their replication. In Fields Virology, 5th edn, pp. 1647–1689. Edited by Knipe, D. M. & Howley, P. M.. Philadelphia. : Lippincott Williams & Wilkins.
[Google Scholar]
Paterson, R. G., Takeda, M., Ohigashi, Y., Pinto, L. H. & Lamb, R. A.(2003). Influenza B virus BM2 protein is an oligomeric integral membrane protein expressed at the cell surface. Virology306, 7–17.[CrossRef][Google Scholar]
Pau, M. G., Ophorst, C., Koldijk, M. H., Schouten, G., Mehtali, M. & Uytdehaag, F.(2001). The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines. Vaccine19, 2716–2721.[CrossRef][Google Scholar]
Powell, M. L., Napthine, S., Jackson, R. J., Brierley, I. & Brown, T. D.(2008). Characterization of the termination-reinitiation strategy employed in the expression of influenza B virus BM2 protein. RNA14, 2394–2406.[CrossRef][Google Scholar]
Qiu, Y. & Krug, R. M.(1994). The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A). J Virol68, 2425–2432.
[Google Scholar]
Robertson, J. S.(1979). 5′ and 3′ terminal nucleotide sequences of the RNA genome segments of influenza virus. Nucleic Acids Res6, 3745–3757.[CrossRef][Google Scholar]
Robertson, J. S., Naeve, C. W., Webster, R. G., Bootman, J. S., Newman, R. & Schild, G. C.(1985). Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs. Virology143, 166–174.[CrossRef][Google Scholar]
Rota, P. A., Wallis, T. R., Harmon, M. W., Rota, J. S., Kendal, A. P. & Nerome, K.(1990). Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology175, 59–68.[CrossRef][Google Scholar]
Sato, Y., Yoshioka, K., Suzuki, C., Awashima, S., Hosaka, Y., Yewdell, J. & Kuroda, K.(2003). Localization of influenza virus proteins to nuclear dot 10 structures in influenza virus-infected cells. Virology310, 29–40.[CrossRef][Google Scholar]
Schneider, J., Dauber, B., Melen, K., Julkunen, I. & Wolff, T.(2009). Analysis of influenza B virus NS1 protein trafficking reveals a novel interaction with nuclear speckle domains. J Virol83, 701–711.[CrossRef][Google Scholar]
Schnell, J. R. & Chou, J. J.(2008). Structure and mechanism of the M2 proton channel of influenza A virus. Nature451, 591–595.[CrossRef][Google Scholar]
Shaw, M. W., Choppin, P. W. & Lamb, R. A.(1983). A previously unrecognized influenza B virus glycoprotein from a bicistronic mRNA that also encodes the viral neuraminidase. Proc Natl Acad Sci U S A80, 4879–4883.[CrossRef][Google Scholar]
Sheu, T. G., Deyde, V. M., Okomo-Adhiambo, M., Garten, R. J., Xu, X., Bright, R. A., Butler, E. N., Wallis, T. R., Klimov, A. I. & other authors(2008). Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob Agents Chemother52, 3284–3292.[CrossRef][Google Scholar]
Skehel, J. J. & Hay, A. J.(1978). Nucleotide sequences at the 5′ termini of influenza virus RNAs and their transcripts. Nucleic Acids Res5, 1207–1219.[CrossRef][Google Scholar]
Smee, D. F., Sidwell, R. W., Morrison, A. C., Bailey, K. W., Baum, E. Z., Ly, L. & Wagaman, P. C.(2001). Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201. Antiviral Res52, 251–259.[CrossRef][Google Scholar]
Snyder, M. H., Betts, R. F., DeBorde, D., Tierney, E. L., Clements, M. L., Herrington, D., Sears, S. D., Dolin, R., Maassab, H. F. & other authors(1988). Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines. J Virol62, 488–495.
[Google Scholar]
Snyder, M. H., London, W. T., Maassab, H. F. & Murphy, B. R.(1989). Attenuation and phenotypic stability of influenza B/Texas/1/84 cold-adapted reassortant virus: studies in hamsters and chimpanzees. J Infect Dis160, 604–610.[CrossRef][Google Scholar]
Sridharan, H., Zhao, C. & Krug, R. M.(2010). Species specificity of the NS1 protein of influenza B virus: NS1 binds only human and non-human primate ubiquitin-like ISG15 proteins. J Biol Chem285, 7852–7856.[CrossRef][Google Scholar]
Stevens, M. P. & Barclay, W. S.(1998). The N-terminal extension of the influenza B virus nucleoprotein is not required for nuclear accumulation or the expression and replication of a model RNA. J Virol72, 5307–5312.
[Google Scholar]
Stoeckle, M. Y., Shaw, M. W. & Choppin, P. W.(1987). Segment-specific and common nucleotide sequences in the noncoding regions of influenza B virus genome RNAs. Proc Natl Acad Sci U S A84, 2703–2707.[CrossRef][Google Scholar]
Stouffer, A. L., Acharya, R., Salom, D., Levine, A. S., Di Costanzo, L., Soto, C. S., Tereshko, V., Nanda, V., Stayrook, S. & other authors(2008). Structural basis for the function and inhibition of an influenza virus proton channel. Nature451, 596–599.[CrossRef][Google Scholar]
Sugaya, N., Mitamura, K., Yamazaki, M., Tamura, D., Ichikawa, M., Kimura, K., Kawakami, C., Kiso, M., Ito, M. & other authors(2007). Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children. Clin Infect Dis44, 197–202.[CrossRef][Google Scholar]
Sunstrom, N. A., Premkumar, L. S., Premkumar, A., Ewart, G., Cox, G. B. & Gage, P. W.(1996). Ion channels formed by NB, an influenza B virus protein. J Membr Biol150, 127–132.[CrossRef][Google Scholar]
Sweet, T. M., Maassab, H. F. & Herlocher, M. L.(2004). Reverse genetics studies of attenuation of the ca A/AA/6/60 influenza virus: the role of the matrix gene. Biomed Pharmacother58, 509–515.[CrossRef][Google Scholar]
Varghese, J. N., Laver, W. G. & Colman, P. M.(1983). Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution. Nature303, 35–40.[CrossRef][Google Scholar]
Versteeg, G. A., Hale, B. G., van Boheemen, S., Wolff, T., Lenschow, D. J. & Garcia-Sastre, A.(2010). Species-specific antagonism of host ISGylation by the influenza B virus NS1 protein. J Virol84, 5423–5430.[CrossRef][Google Scholar]
von Itzstein, M., Wu, W. Y., Kok, G. B., Pegg, M. S., Dyason, J. C., Jin, B., Van Phan, T., Smythe, M. L., White, H. F. & other authors(1993). Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature363, 418–423.[CrossRef][Google Scholar]
Wang, Z. & Duke, G. M.(2007). Cloning of the canine RNA polymerase I promoter and establishment of reverse genetics for influenza A and B in MDCK cells. Virol J4, 102.[CrossRef][Google Scholar]
Wang, W. & Krug, R. M.(1996). The RNA-binding and effector domains of the viral NS1 protein are conserved to different extents among influenza A and B viruses. Virology223, 41–50.[CrossRef][Google Scholar]
Watanabe, S., Imai, M., Ohara, Y. & Odagiri, T.(2003). Influenza B virus BM2 protein is transported through the trans-Golgi network as an integral membrane protein. J Virol77, 10630–10637.[CrossRef][Google Scholar]
Williams, M. A. & Lamb, R. A.(1986). Determination of the orientation of an integral membrane protein and sites of glycosylation by oligonucleotide-directed mutagenesis: influenza B virus NB glycoprotein lacks a cleavable signal sequence and has an extracellular NH2-terminal region. Mol Cell Biol6, 4317–4328.
[Google Scholar]
Williams, M. A. & Lamb, R. A.(1988). Polylactosaminoglycan modification of a small integral membrane glycoprotein, influenza B virus NB. Mol Cell Biol8, 1186–1196.
[Google Scholar]
Williams, M. A. & Lamb, R. A.(1989). Effect of mutations and deletions in a bicistronic mRNA on the synthesis of influenza B virus NB and NA glycoproteins. J Virol63, 28–35.
[Google Scholar]
Wise, H. M., Foeglein, A., Sun, J., Dalton, R. M., Patel, S., Howard, W., Anderson, E. C., Barclay, W. S. & Digard, P.(2009). A complicated message: identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J Virol83, 8021–8031.[CrossRef][Google Scholar]
Wressnigg, N., Shurygina, A. P., Wolff, T., Redlberger-Fritz, M., Popow-Kraupp, T., Muster, T., Egorov, A. & Kittel, C.(2009a). Influenza B mutant viruses with truncated NS1 proteins grow efficiently in Vero cells and are immunogenic in mice. J Gen Virol90, 366–374.[CrossRef][Google Scholar]
Wressnigg, N., Voss, D., Wolff, T., Romanova, J., Ruthsatz, T., Mayerhofer, I., Reiter, M., Nakowitsch, S., Humer, J. & other authors(2009b). Development of a live-attenuated influenza B ΔNS1 intranasal vaccine candidate. Vaccine27, 2851–2857.[CrossRef][Google Scholar]
Yuan, W. & Krug, R. M.(2001). Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J20, 362–371.[CrossRef][Google Scholar]
Yuan, W., Aramini, J. M., Montelione, G. T. & Krug, R. M.(2002). Structural basis for ubiquitin-like ISG 15 protein binding to the NS1 protein of influenza B virus: a protein-protein interaction function that is not shared by the corresponding N-terminal domain of the NS1 protein of influenza A virus. Virology304, 291–301.[CrossRef][Google Scholar]
Zambon, M. & Hayden, F. G.(2001). Position statement: global neuraminidase inhibitor susceptibility network. Antiviral Res49, 147–156.[CrossRef][Google Scholar]
Zebedee, S. L. & Lamb, R. A.(1988). Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J Virol62, 2762–2772.
[Google Scholar]
Zhirnov, O. P.(1992). Isolation of matrix protein M1 from influenza viruses by acid-dependent extraction with nonionic detergent. Virology186, 324–330.[CrossRef][Google Scholar]